Title | Type | SJR | H index | Total Docs. (2012) | Total Docs. (3years) | Total Refs. (2012) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2012) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Pharmacological Reviews | journal | 10.673 Q1 | 247 | 36 | 74 | 12166 | 1845 | 74 | 25.93 | 337.94 | |
2 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.120 Q1 | 79 | 12 | 34 | 2387 | 151 | 34 | 3.36 | 198.92 | |
3 | Advances in Molecular Toxicology | book series | 0.442 Q3 | 17 | 8 | 23 | 1491 | 37 | 13 | 1.67 | 186.38 | |
4 | Reviews of Physiology Biochemistry and Pharmacology | journal | 69 | 10 | 0 | 1845 | 0 | 0 | 0.00 | 184.50 | ||
5 | Pharmacology and Therapeutics | journal | 3.668 Q1 | 220 | 108 | 307 | 19821 | 3154 | 303 | 9.47 | 183.53 | |
6 | Medicinal Research Reviews | journal | 2.488 Q1 | 141 | 38 | 76 | 6847 | 646 | 74 | 7.59 | 180.18 | |
7 | Food and Drug Law Journal | journal | 0.173 Q4 | 23 | 23 | 92 | 4024 | 38 | 91 | 0.28 | 174.96 | |
8 | Advances in Pharmacology | journal | 2.207 Q1 | 81 | 34 | 86 | 5270 | 422 | 10 | 5.33 | 155.00 | |
9 | Current Neuropharmacology | journal | 0.799 Q2 | 93 | 35 | 170 | 4661 | 494 | 162 | 2.30 | 133.17 | |
10 | Drug Resistance Updates | journal | 3.276 Q1 | 125 | 26 | 62 | 3117 | 624 | 60 | 10.15 | 119.88 | |
11 | Current Medicinal Chemistry | journal | 1.538 Q1 | 192 | 504 | 1001 | 59089 | 5163 | 970 | 4.56 | 117.24 | |
12 | Annual Review of Pharmacology and Toxicology | journal | 10.673 Q1 | 218 | 26 | 54 | 3020 | 1334 | 54 | 24.89 | 116.15 | |
13 | Current Pharmaceutical Design | journal | 1.280 Q1 | 176 | 585 | 1163 | 65504 | 4809 | 1058 | 3.76 | 111.97 | |
14 | Current Cancer Drug Targets | journal | 1.789 Q1 | 99 | 89 | 255 | 9901 | 1290 | 238 | 4.32 | 111.25 | |
15 | Current Drug Metabolism | journal | 1.139 Q1 | 118 | 131 | 261 | 14321 | 1309 | 232 | 4.50 | 109.32 | |
16 | Cellular and Molecular Life Sciences | journal | 3.403 Q1 | 248 | 293 | 899 | 30443 | 6407 | 889 | 6.45 | 103.90 | |
17 | Progress in Medicinal Chemistry | journal | 1.110 Q1 | 37 | 5 | 26 | 518 | 58 | 12 | 2.25 | 103.60 | |
18 | Drugs in Context | journal | 32 | 3 | 0 | 310 | 0 | 0 | 0.00 | 103.33 | ||
19 | Current Molecular Pharmacology | journal | 1.560 Q1 | 46 | 39 | 59 | 3998 | 290 | 57 | 4.38 | 102.51 | |
20 | Expert Opinion on Emerging Drugs | journal | 0.898 Q2 | 52 | 44 | 137 | 4301 | 470 | 137 | 3.09 | 97.75 | |
21 | Current Drug Targets | journal | 1.332 Q1 | 112 | 194 | 483 | 18772 | 1873 | 438 | 4.20 | 96.76 | |
22 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.502 Q3 | 42 | 34 | 78 | 3271 | 168 | 78 | 1.96 | 96.21 | |
23 | Anti-Cancer Agents in Medicinal Chemistry | journal | 1.027 Q2 | 103 | 121 | 293 | 11637 | 971 | 261 | 3.00 | 96.17 | |
24 | Journal of Experimental Pharmacology | journal | 0.121 Q4 | 18 | 2 | 1 | 192 | 0 | 1 | 0.00 | 96.00 | |
25 | Neurotherapeutics | journal | 2.526 Q1 | 129 | 67 | 196 | 6383 | 1359 | 182 | 6.94 | 95.27 | |
26 | Issues in Toxicology | book series | 0.195 Q3 | 17 | 72 | 68 | 6768 | 52 | 64 | 0.72 | 94.00 | |
27 | Mini-Reviews in Medicinal Chemistry | journal | 0.941 Q2 | 101 | 140 | 364 | 12246 | 1254 | 356 | 3.40 | 87.47 | |
28 | Frontiers in Pharmacology | journal | 0.717 Q2 | 129 | 206 | 129 | 17703 | 312 | 125 | 2.42 | 85.94 | |
29 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.942 Q2 | 95 | 127 | 366 | 10730 | 1396 | 363 | 3.62 | 84.49 | |
30 | Pharmacogenomics and Personalized Medicine | journal | 0.150 Q4 | 34 | 11 | 31 | 914 | 13 | 31 | 0.55 | 83.09 | |
31 | Expert Opinion on Therapeutic Targets | journal | 1.788 Q1 | 101 | 138 | 337 | 11271 | 1537 | 335 | 4.37 | 81.67 | |
32 | Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry | journal | 0.235 Q3 | 16 | 34 | 78 | 2748 | 37 | 70 | 0.39 | 80.82 | |
33 | Open Pharmacology Journal | journal | 0.201 Q3 | 6 | 5 | 10 | 400 | 11 | 10 | 1.80 | 80.00 | |
34 | Open Neuropsychopharmacology Journal | journal | 0.183 Q3 | 6 | 3 | 20 | 238 | 11 | 19 | 0.38 | 79.33 | |
35 | Expert Opinion on Therapeutic Patents | journal | 1.330 Q1 | 83 | 100 | 339 | 7922 | 1228 | 333 | 3.46 | 79.22 | |
36 | Expert Opinion on Investigational Drugs | journal | 1.486 Q1 | 114 | 161 | 456 | 12444 | 2061 | 446 | 4.32 | 77.29 | |
37 | Neuropharmacology | journal | 2.315 Q1 | 184 | 408 | 798 | 31474 | 4102 | 782 | 4.39 | 77.14 | |
38 | Infectious Disorders - Drug Targets | journal | 0.593 Q2 | 59 | 47 | 145 | 3616 | 275 | 129 | 1.89 | 76.94 | |
39 | Clinical Pharmacokinetics | journal | 2.254 Q1 | 176 | 56 | 179 | 4291 | 1220 | 160 | 7.02 | 76.63 | |
40 | Side Effects of Drugs Annual | book series | 0.102 Q4 | 7 | 53 | 157 | 4034 | 4 | 53 | 0.02 | 76.11 | |
41 | Current Vascular Pharmacology | journal | 0.975 Q2 | 67 | 107 | 217 | 8016 | 742 | 205 | 3.13 | 74.92 | |
42 | Inflammation and Allergy - Drug Targets | journal | 0.973 Q2 | 54 | 66 | 153 | 4860 | 536 | 140 | 2.65 | 73.64 | |
43 | CNS and Neurological Disorders - Drug Targets | journal | 1.492 Q1 | 93 | 123 | 237 | 9055 | 912 | 208 | 3.68 | 73.62 | |
44 | Future Medicinal Chemistry | journal | 1.047 Q1 | 84 | 191 | 426 | 13920 | 1085 | 338 | 2.58 | 72.88 | |
45 | Clinical Medicine Insights: Therapeutics | journal | 0.109 Q4 | 10 | 22 | 83 | 1600 | 13 | 83 | 0.16 | 72.73 | |
46 | BioDrugs | journal | 1.106 Q1 | 76 | 42 | 130 | 3053 | 545 | 127 | 3.61 | 72.69 | |
47 | Therapeutic Advances in Neurological Disorders | journal | 0.789 Q2 | 62 | 28 | 93 | 1970 | 300 | 89 | 4.02 | 70.36 | |
48 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.183 Q3 | 26 | 35 | 109 | 2441 | 66 | 98 | 0.47 | 69.74 | |
49 | Current Psychopharmacology | journal | 4 | 1 | 0 | 69 | 0 | 0 | 0.00 | 69.00 | ||
50 | Trends in Pharmacological Sciences | journal | 5.103 Q1 | 234 | 86 | 252 | 5885 | 2978 | 238 | 10.50 | 68.43 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2022. Data Source: Scopus®